Germline melanoma susceptibility and prognostic genes: a review of the literature

Journal of the American Academy of Dermatology
Katherine A WardMaria K Hordinsky

Abstract

In recent years, there have been increasing efforts to identify germline genetic variants that may alter melanoma susceptibility and prognosis. The findings of these studies have indicated the presence of rare, high-penetrance alleles with large effects, such as CDKN2A and CDK4, more common, moderately penetrant genes like MC1R, and very common, low-penetrance polymorphisms with small effects that are related to pigmentation, nevus count, immune responses, DNA repair, metabolism, and the vitamin D receptor. The study of these low-penetrance single nucleotide polymorphisms is relatively new; thus many of them are termed 'candidate melanoma susceptibility or prognostic genes.' This review summarizes the research on germline polymorphisms that have been implicated in melanoma susceptibility and prognosis in order to provide a framework for additional studies to meet the ultimate goal of predicting a patient's risk of, and prognosis in, cutaneous malignant melanoma.

References

May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A R BakerB W O'Malley
Apr 1, 1985·Annals of Internal Medicine·M H GreeneM C Fraser
Nov 15, 1994·International Journal of Cancer. Journal International Du Cancer·J E LeeC D Platsoucas
Sep 1, 1994·Nature Genetics·C J HussussianN C Dracopoli
Nov 1, 1995·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·F M MarincolaD R Parkinson
Jan 1, 1996·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·A van de Stolpe, P T van der Saag
May 8, 1998·Biochemical and Biophysical Research Communications·P A FrändbergV Chhájlani
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·T KamijoC J Sherr
Jul 15, 1999·Biochemical and Biophysical Research Communications·H B SchiöthJ L Rees
Sep 24, 1999·IARC Scientific Publications·C R Wolf, G Smith
Oct 28, 1999·The Journal of Investigative Dermatology. Symposium Proceedings·I SuzukiZ Abdel-Malek
Jun 7, 2000·Pigment Cell Research·R Buscà, R Ballotti
Dec 21, 2000·Current Oncology Reports·N Hayward
Jan 10, 2001·International Journal of Cancer. Journal International Du Cancer·L LusiniP Di Simplicio
Aug 14, 2001·American Journal of Human Genetics·N F BoxN K Hayward
Aug 14, 2001·American Journal of Human Genetics·P A van der VeldenN A Gruis
Feb 8, 2002·American Journal of Human Genetics·Peter A KanetskyTimothy R Rebbeck
Oct 11, 2002·Annals of Surgical Oncology·Vernon K Sondak, Alfred E Chang
Oct 24, 2002·Melanoma Research·J A Martínez-EscribanoM R Alvarez-López
Nov 9, 2002·The Lancet Oncology·Richard KeffordUNKNOWN Melanoma Genetics Consortium
Jan 17, 2003·Molecular Human Reproduction·P ViganòA M DiBlasio
May 20, 2003·Pigment Cell Research·Richard A SturmNicholas G Martin
Jun 6, 2003·Oncogene·Nicholas K Hayward
Jun 6, 2003·Oncogene·E Sharpless, Lynda Chin
Dec 17, 2003·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·W M HowellA C Bateman
Jun 8, 2004·Current Drug Metabolism·Jose A G Agundez
Jul 1, 2004·The Journal of Steroid Biochemistry and Molecular Biology·Markus SeifertJörg Reichrath
Dec 25, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sara GandiniCarmelo Francesco Melchi
May 10, 2005·Genes, Chromosomes & Cancer·Anders MolvenLars A Akslen

❮ Previous
Next ❯

Citations

May 18, 2013·Pathology Oncology Research : POR·Veronika TóthSarolta Kárpáti
Sep 18, 2012·BMC Medical Genetics·Cristina PellegriniKetty Peris
Apr 20, 2014·PloS One·Yoana Arroyo-BerdugoMaría Dolores Boyano
Sep 23, 2014·Experimental and Molecular Pathology·Erica Sara Souza de AraújoAna Cristina Victorino Krepischi
Oct 1, 2013·Dermatologic Clinics·Susana Puig, Josep Malvehy
Mar 26, 2016·The Journal of Investigative Dermatology·Katerina P KypreouAlexander I Stratigos
Jun 17, 2014·Neoplasia : an International Journal for Oncology Research·Rona OrtenbergGal Markel
Sep 6, 2015·Pigment Cell & Melanoma Research·Matjaz VogelsangTomas Kirchhoff
Oct 1, 2014·The Journal of Investigative Dermatology·Charles LuArmita Bahrami
May 11, 2013·Pigment Cell & Melanoma Research·Salina M TorresMarianne Berwick
Sep 6, 2012·Pigment Cell & Melanoma Research·Marianne Berwick, Eszter O Erdei
Mar 30, 2016·Future Oncology·Felipe FidalgoAna Cristina Victorino Krepischi
Dec 3, 2014·Journal of the American Academy of Dermatology·Era Caterina MurzakuBabar K Rao
Mar 22, 2016·Expert Review of Anticancer Therapy·Nora WoltscheIris Zalaudek
Aug 1, 2015·Annals of Surgical Oncology·Danielle K DePeralta, Genevieve M Boland
Aug 12, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Tianhui ChenMahdi Fallah
Jan 22, 2015·Journal of Medical Genetics·Justin RendlemanTomas Kirchhoff
Apr 23, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jeong Hee Cho-Vega
Sep 15, 2018·Pigment Cell & Melanoma Research·Filipe V AlmeidaAshani T Weeraratna
Jan 1, 2015·Nature Reviews. Disease Primers·Dirk SchadendorfAxel Hauschild
Nov 26, 2014·Experimental Dermatology·Jenna R BordelonJames M Grichnik
Feb 10, 2016·Journal of the National Cancer Institute·David C GibbsUNKNOWN GEM Study Group
Feb 1, 2015·Melanoma Management·Kachiu C LeeAbrar A Qureshi
Dec 14, 2016·Annual Review of Pathology·William M Lin, David E Fisher
Jun 28, 2016·International Journal of Cancer. Journal International Du Cancer·Amaury VaysseFlorence Demenais

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Related Papers

Seminars in Cutaneous Medicine and Surgery
Durga UdayakumarHensin Tsao
Human Genetics
Kathrine Damm Meyle, Per Guldberg
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]
S PuigJosep Malvehy
© 2021 Meta ULC. All rights reserved